User:Patrick Wiencek/AHNAK

From Proteopedia

< User:Patrick Wiencek(Difference between revisions)
Jump to: navigation, search
Current revision (21:18, 4 May 2018) (edit) (undo)
 
(24 intermediate revisions not shown.)
Line 15: Line 15:
AHNAK has a unique structure made up of three main domains: the N-terminal domain, the central repeated domain, and the C-terminal domain (Figure 1). These domains are 251, 4300, and 1002 amino acids in length, respectively <ref name="a1" /><ref name="a8" />.
AHNAK has a unique structure made up of three main domains: the N-terminal domain, the central repeated domain, and the C-terminal domain (Figure 1). These domains are 251, 4300, and 1002 amino acids in length, respectively <ref name="a1" /><ref name="a8" />.
-
[[Image:AHNAKFigure1.1.jpg|500px|right|thumb|Figure 1. A structural representation of AHNAK, including sites of protein interaction. Modified from <ref name="a1" />]]
+
[[Image:AHNAKFigure1.1.jpg|500px|left|thumb|Figure 1. A structural representation of AHNAK, including sites of protein interaction. Modified from <ref name="a1" />]]
=== The Central Repeated Domain ===
=== The Central Repeated Domain ===
Line 36: Line 36:
The β2 subunit of Ca<sub>v</sub> channels will interact with residues 5262-5643 of the C-terminal domain of AHNAK <ref name="a13">DOI:10.1096/fj.01-0855com</ref>.
The β2 subunit of Ca<sub>v</sub> channels will interact with residues 5262-5643 of the C-terminal domain of AHNAK <ref name="a13">DOI:10.1096/fj.01-0855com</ref>.
*'''Calpain 3'''
*'''Calpain 3'''
-
There are 5 cleavage sites for Calpain in AHNAK, 2 are in the N-terminus and 3 are in the C-terminus.
+
There are 5 cleavage sites for Calpain in AHNAK, 2 are in the N-terminus and 3 are in the C-terminus <ref name="a14">Huang, Y. et al. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum. Mol. Genet. 17, 1855–1866 (2008).</ref>.
*'''Dysfurlin'''
*'''Dysfurlin'''
-
The N-terminal region of dysfurlin will interact with the C-terminal domain of AHNAK from residues 5146 – 5643.
+
The N-terminal region of dysfurlin will interact with the C-terminal domain of AHNAK from residues 5146 – 5643 <ref name="a15">Huang, Y. et al. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J. 21, 732–742 (2006).</ref>.
*'''DNA'''
*'''DNA'''
-
AHNAK has been shown having weak DNA binding affinity similar to the Ku protein <ref name="a16">DOI:10.1016/j.dnarep.2003.11.001</ref>. Sequence alignment of AHNAK with Ku70 (Uniprot P13010)and Ku80 (Uniprot P12956) indicated areas of similarity from residues 1-200 and 4661-5260 respectively (Figure 3) <sup>[17]</sup>. These sites may be AHNAK’s prospective DNA binding sites.
+
AHNAK has been shown having weak DNA binding affinity similar to the Ku protein <ref name="a16">DOI:10.1016/j.dnarep.2003.11.001</ref>. Sequence alignment of AHNAK with Ku70 (Uniprot P13010)and Ku80 (Uniprot P12956) indicated areas of similarity from residues 1-200 and 4661-5260 respectively (Figure 3) <ref name="a17">EMBOSS Needle < Pairwise Sequence Alignment < EMBL-EBI. Available at: https://www.ebi.ac.uk/Tools/psa/emboss_needle/. (Accessed: 2nd May 2018)</ref>. These sites may be AHNAK’s prospective DNA binding sites.
[[Image:AHNAKFigureKu.2.jpg|400px|right|thumb|Figure 3. A visual representation of AHNAK's amino acid sequence and its sites of similarity with the proteins XRCC5 and XRCC6.]]
[[Image:AHNAKFigureKu.2.jpg|400px|right|thumb|Figure 3. A visual representation of AHNAK's amino acid sequence and its sites of similarity with the proteins XRCC5 and XRCC6.]]
*'''Protein Kinase B (PKB)'''
*'''Protein Kinase B (PKB)'''
-
PKB will phosphorylate serine 5535 in AHNAK’s C-terminal domain <sup>[6]</sup>. This will activate AHNAK’s nuclear export signal, allowing it to move out of the nucleus. AHNAK’s nuclear export signal is made up of 5 different motifs in the C-terminal domain: (4971-4979), (5019-5027), (5034-5039), (5706-5716), and (5772-5779) <sup>[18]</sup>.
+
PKB will phosphorylate serine 5535 in AHNAK’s C-terminal domain <ref name="a6" />. This will activate AHNAK’s nuclear export signal, allowing it to move out of the nucleus. AHNAK’s nuclear export signal is made up of 5 different motifs in the C-terminal domain: (4971-4979), (5019-5027), (5034-5039), (5706-5716), and (5772-5779) <ref name="a18">AHNAK - Neuroblast differentiation-associated protein AHNAK - Homo sapiens (Human) - AHNAK gene & protein. Available at: https://www.uniprot.org/uniprot/Q09666#ptm_processing. (Accessed: 1st May 2018)</ref>.
*'''Protein Kinase C α (PKCα)'''
*'''Protein Kinase C α (PKCα)'''
-
PKCα will bind to and is activated by AHNAK <sup>[19]</sup>. This interaction occurs in AHNAK’s central repeated domain (3859-4412).
+
PKCα will bind to and is activated by AHNAK <ref name="a19">PMID:18174170</ref>. This interaction occurs in AHNAK’s central repeated domain (3859-4412).
*'''Phospholipase C γ (PLCγ)'''
*'''Phospholipase C γ (PLCγ)'''
-
PLCγ will bind AHNAK in its central repeated domain in residues 3740-3882 and 3859-4412 <sup>[20]</sup>. AHNAK also activated bound PLCγ.
+
PLCγ will bind AHNAK in its central repeated domain in residues 3740-3882 and 3859-4412 <ref name="a20">PMID:10318799</ref>. AHNAK also activated bound PLCγ.
*'''Regulatory Samds (R-Smads)'''
*'''Regulatory Samds (R-Smads)'''
-
The MH2 domain of Smad2 will bind to the central repetitive domain of AHNAK from residues 4105-4633 <sup>[21]</sup>.
+
The MH2 domain of Smad2 will bind to the central repetitive domain of AHNAK from residues 4105-4633 <ref name="a21">DOI:10.1038/onc.2014.69</ref>.
-
It is also of not that AHNAK does not have a calcium binding domain, despite it responding to calcium signaling. Calcium sensing might be facilitated by AHNAK’s interaction with annexin 2, which is calcium sensitive <ref name="a1" /><sup>[22,23]</sup>.
+
It is also of not that AHNAK does not have a calcium binding domain, despite it responding to calcium signaling. Calcium sensing might be facilitated by AHNAK’s interaction with annexin 2, which is calcium sensitive <ref name="a1" /><ref name="a22">DOI:10.1155/2012/852430</ref><ref name="a23">PMID:21949189</ref>.
== '''Function''' ==
== '''Function''' ==
Line 57: Line 57:
AHNAK has a diverse list of biological processes that is has been implicated in, including cell signaling and cell contacts, regulation of calcium channels, membrane repair, and interaction with DNA ligase (Figure 4) <ref name="a1" />. AHNAK has been implicated in each of these biological processes, each with a description of its role:
AHNAK has a diverse list of biological processes that is has been implicated in, including cell signaling and cell contacts, regulation of calcium channels, membrane repair, and interaction with DNA ligase (Figure 4) <ref name="a1" />. AHNAK has been implicated in each of these biological processes, each with a description of its role:
-
[[Image:AHNAKFigure2.1.jpg|400px|right|thumb|Figure 4. A visual representation of many of AHNAK's functions and how those functions relate to disease. Modified from <ref name="a1" />]]
+
[[Image:AHNAKFigure2.1.jpg|400px|left|thumb|Figure 4. A visual representation of many of AHNAK's functions and how those functions relate to disease. Modified from <ref name="a1" />]]
=== Cell signaling ===
=== Cell signaling ===
-
The central repetitive domain of AHNAK has been shown binding and activating the signaling proteins PKCα and PLCγ <sup>[19,20]</sup>. This activation has been demonstrated as having a downstream activating effect on the RAF/MEK/ERK pathway, which in turn regulates gene expression <sup>[19,20,24]</sup>. The central repetitive domain of AHNAK has also been shown to play a role in the TGFβ and Smad signaling pathway <sup>[21]</sup>. AHNAK can interact with and translocate regulatory-Smad proteins 1-3 to the nucleus. This translocation increases the binding of phosphor-Smad3 to the c-Myc promoter, resulting in decreased c-Myc expression and in turn less cell proliferation. AHNAK overexpression in mouse fibroblast cells resulted in an accumulation of cells in the G0 and G1 phases of the cell cycle, indicating cell cycle arrest <sup>[21]</sup>.
+
The central repetitive domain of AHNAK has been shown binding and activating the signaling proteins PKCα and PLCγ <ref name="a19" /><ref name="a20" />. This activation has been demonstrated as having a downstream activating effect on the RAF/MEK/ERK pathway, which in turn regulates gene expression <ref name="a19" /><ref name="a20" /><ref name="a24">PMID:12835716</ref>. The central repetitive domain of AHNAK has also been shown to play a role in the TGFβ and Smad signaling pathway <ref name="a21" />. AHNAK can interact with and translocate regulatory-Smad proteins 1-3 to the nucleus. This translocation increases the binding of phosphor-Smad3 to the c-Myc promoter, resulting in decreased c-Myc expression and in turn less cell proliferation. AHNAK overexpression in mouse fibroblast cells resulted in an accumulation of cells in the G0 and G1 phases of the cell cycle, indicating cell cycle arrest <ref name="a21" />.
=== Neurogenesis ===
=== Neurogenesis ===
-
AHNAK has been associated with several different processes involving neurogenesis. In the peripheral nervous system AHNAK might play a role in myelination <sup>[25,26]</sup>. AHNAK is expressed during the period of laminin deposition and myelination in Schwann cells, and AHNAK knockdown showed detachment from laminin substrates. In the central nervous system AHNAK was implicated in the formation of the blood brain barrier, as endothelial cells forming the blood brain barrier had increased AHNAK expression levels compared to those not forming the blood brain barrier <sup>[27]</sup>. AHNAK null mice displayed increased levels of hippocampal neurogenesis in adult mice, indicating that AHNAK might be involved in modulating the differentiation of new cells to neuronal or non-neuronal cells <sup>[28]</sup>.
+
AHNAK has been associated with several different processes involving neurogenesis. In the peripheral nervous system AHNAK might play a role in myelination <ref name="a25">Boxberg, Y. V. et al. Spinal cord injury-induced up-regulation of AHNAK, expressed in cells delineating cystic cavities, and associated with neoangiogenesis. Eur. J. Neurosci. 24, 1031–1041 (2006).</ref><ref name="a26">DOI:10.1002/glia.20782</ref>. AHNAK is expressed during the period of laminin deposition and myelination in Schwann cells, and AHNAK knockdown showed detachment from laminin substrates. In the central nervous system AHNAK was implicated in the formation of the blood brain barrier, as endothelial cells forming the blood brain barrier had increased AHNAK expression levels compared to those not forming the blood brain barrier <ref name="a27">DOI:10.1002/jcp.20232</ref>. AHNAK null mice displayed increased levels of hippocampal neurogenesis in adult mice, indicating that AHNAK might be involved in modulating the differentiation of new cells to neuronal or non-neuronal cells <ref name="a28">PMID:26007245</ref>.
=== Cell-Cell contact formation ===
=== Cell-Cell contact formation ===
-
In addition to phosphorylation by PKB, AHNAK localization in epithelial cells depends on cell confluency, where sub-confluent cells displayed a nuclear localization while confluent cells displayed a cytoplasmic or plasma membrane localization <sup>[6]</sup>. When AHNAK re-localizes to the plasma membrane it complexes with actin and heterotetrameric annexin2/S100A10 <sup>[7]</sup>. A structural analysis of this complex reveals that both annexin2 and S100A10 are necessary for the complex to form <sup>[29]</sup>. A possible mechanism for calcium dependent cell-cell contact formation is that PKB phosphorylation of AHNAK will cause its translocation to the plasma membrane where it complexes with actin and annexin2/S100A10 <ref name="a1" /><sup>[6,7]</sup>.
+
In addition to phosphorylation by PKB, AHNAK localization in epithelial cells depends on cell confluency, where sub-confluent cells displayed a nuclear localization while confluent cells displayed a cytoplasmic or plasma membrane localization <ref name="a6" />. When AHNAK re-localizes to the plasma membrane it complexes with actin and heterotetrameric annexin2/S100A10 <ref name="a7" />. A structural analysis of this complex reveals that both annexin2 and S100A10 are necessary for the complex to form <ref name="a29">DOI:10.1016/j.str.2012.08.004</ref>. A possible mechanism for calcium dependent cell-cell contact formation is that PKB phosphorylation of AHNAK will cause its translocation to the plasma membrane where it complexes with actin and annexin2/S100A10 <ref name="a1" /><ref name="a6" /><ref name="a7" />.
=== Calcium channels ===
=== Calcium channels ===
-
AHNAK can bind the β2 subunit of L-type voltage gated calcium (Cav ) channels in cardiomyocytes <sup>[13]</sup>. AHNAK seems to have different effects on calcium channels and from calcium across the cited studies. This may be due to different calcium channel isoforms, or different cell types (and thus different responses to calcium) <ref name="a1" />. One hypothesis of AHNAK function with the β2 subunit is that following β-adrenergic stimulation and phosphorylation of AHNAK by PKA, AHNAK will release the β2 subunit of the Cav channel and allow normal calcium influx <sup>[31]</sup>. AHNAK was also implicated in calcium influx in CD4+ T cells and cytotoxic CD8+ effector T-cells <sup>[32,33]</sup>. Here, AHNAK null mice showed decreased calcium influx, leading experts to hypothesize that the underlying mechanism involved AHNAK assisting the β2-subunit in membrane localization <sup>[34]</sup>.
+
AHNAK can bind the β2 subunit of L-type voltage gated calcium (Cav ) channels in cardiomyocytes <ref name="a13" />. AHNAK seems to have different effects on calcium channels and from calcium across the cited studies. This may be due to different calcium channel isoforms, or different cell types (and thus different responses to calcium) <ref name="a1" />. One hypothesis of AHNAK function with the β2 subunit is that following β-adrenergic stimulation and phosphorylation of AHNAK by PKA, AHNAK will release the β2 subunit of the Cav channel and allow normal calcium influx <ref name="a30">PMID: 14722071</ref>. AHNAK was also implicated in calcium influx in CD4+ T cells and cytotoxic CD8+ effector T-cells <ref name="a31">DOI:10.1016/j.immuni.2007.11.020</ref><ref name="a32">DOI:10.1073/pnas.0902844106</ref>. Here, AHNAK null mice showed decreased calcium influx, leading experts to hypothesize that the underlying mechanism involved AHNAK assisting the β2-subunit in membrane localization <ref name="a33">DOI:10.1074/jbc.270.50.30036</ref>.
=== Membrane repair ===
=== Membrane repair ===
-
AHNAK is involved in the process of membrane repair through its presence in enlargeosomes, vesicles that fuse with the plasma membrane for differentiation and membrane repair <sup>[35]</sup>. AHNAK typically marks these enlargeosomes just below the plasma membrane. When stimulated with ionomycin AHNAK will label the plasma membrane, as would be expected from a membrane fusion event <sup>[35]</sup>. AHNAK co-localizes and interacts with a membrane repair protein dysferlin, which also interacts with the annexin2/S100A10 complex <sup>[15,36]</sup>. AHNAK’s interaction with S100A10 is small enough to allow it to still interact with dysferlin <sup>[23,29]</sup>. This complex may be regulated by calpain 3, a protease that has been implicated in limb girdle muscular dystrophy A2 along with dysferlin and was experimentally shown to cleave AHNAK <sup>[14]</sup>.
+
AHNAK is involved in the process of membrane repair through its presence in enlargeosomes, vesicles that fuse with the plasma membrane for differentiation and membrane repair <ref name="a34">DOI:10.1038/ncb888</ref>. AHNAK typically marks these enlargeosomes just below the plasma membrane. When stimulated with ionomycin AHNAK will label the plasma membrane, as would be expected from a membrane fusion event <ref name="a34"/>. AHNAK co-localizes and interacts with a membrane repair protein dysferlin, which also interacts with the annexin2/S100A10 complex <ref name="a15" /><ref name="a35">DOI:10.1074/jbc.M307247200</ref>. AHNAK’s interaction with S100A10 is small enough to allow it to still interact with dysferlin <ref name="a23"/><ref name="a29"/>. This complex may be regulated by calpain 3, a protease that has been implicated in limb girdle muscular dystrophy A2 along with dysferlin and was experimentally shown to cleave AHNAK <ref name="a14"/>.
=== Repair of double strand breaks ===
=== Repair of double strand breaks ===
-
In 2004, AHNAK was published interacting specifically with the DNA ligase IB-XRCC4 complex, which is involved in non-homologous end joining <sup>[16]</sup>. This interaction is not observed with AHNAK and other DNA ligases. AHNAK was shown having a weak DNA-binding affinity by itself, but formed a more stable complex when complexed with DNA and DNA ligase.
+
In 2004, AHNAK was published interacting specifically with the DNA ligase IB-XRCC4 complex, which is involved in non-homologous end joining <ref name="a16" />. This interaction is not observed with AHNAK and other DNA ligases. AHNAK was shown having a weak DNA-binding affinity by itself, but formed a more stable complex when complexed with DNA and DNA ligase.
== '''AHNAK in Disease''' ==
== '''AHNAK in Disease''' ==
-
Despite initial mouse models that showed no phenotypic defects in AHNAK-null mice, AHNAK has been related to several different diseases <sup>[10,37]</sup>. These include but are not limited to: cancer, obesity, and aging <ref name="a1" /><sup>[38-40]</sup>.
+
Despite initial mouse models that showed no phenotypic defects in AHNAK-null mice, AHNAK has been related to several different diseases <ref name="a10" /><ref name="a36">DOI:10.1111/j.0022-202X.2004.23412.x</ref>. These include but are not limited to: cancer, obesity, and aging <ref name="a1" /><ref name="a37">PMID:26457177</ref><ref name="a38">PMID:19189975</ref><ref name="a39">DOI:10.1152/ajpendo.90255.2008</ref>.
=== Cancer ===
=== Cancer ===
-
AHNAK’s roles in cancer and tumor metastasis have recently become a large part of the research being done with AHNAK. Due to AHNAK’s implications in many different biological processes, AHNAK seems to promote cancer in some contexts <sup>[30,41]</sup>, and serve as a tumor suppressor in others <sup>[3,4,21]</sup>. Due to its functionality in cytoskeletal stabilization and interaction with actin filaments, AHNAK was found to be essential in actin-rich pseudopod protrusion across several different metastatic human tumor cell lines <sup>[30]</sup>. AHNAK knockdown caused these cells to retract their pseudopods and reverse the epithelial to mesenchymal transition that is necessary for cancer metastasis <sup>[30]</sup>. Similarly, significantly higher levels of AHNAK expression were detected in mesotheliomal cell lines, and migration and invasion were both decreased following AHNAK knockdown <sup>[41]</sup>.
+
AHNAK’s roles in cancer and tumor metastasis have recently become a large part of the research being done with AHNAK. Due to AHNAK’s implications in many different biological processes, AHNAK seems to promote cancer in some contexts <ref name="a40">DOI:10.1158/0008-5472.CAN-09-4439</ref><ref name="a41">Sudo, H. et al. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma. Int. J. Oncol. 44, 530–538 (2014).</ref>, and serve as a tumor suppressor in others <ref name="a3" /><ref name="a4" /><ref name="a21" />. Due to its functionality in cytoskeletal stabilization and interaction with actin filaments, AHNAK was found to be essential in actin-rich pseudopod protrusion across several different metastatic human tumor cell lines <ref name="a40" />. AHNAK knockdown caused these cells to retract their pseudopods and reverse the epithelial to mesenchymal transition that is necessary for cancer metastasis <ref name="a40" />. Similarly, significantly higher levels of AHNAK expression were detected in mesotheliomal cell lines, and migration and invasion were both decreased following AHNAK knockdown <ref name="a41" />.
-
AHNAK can also act as a tumor suppressor because of its role in the TFGβ/Smad pathway <sup>[21]</sup>. Overexpression of AHNAK in mouse fibroblast cell resulted in increased cell-cycle arrest. Analysis of AHNAK mRNA levels in glioma demonstrated that AHNAK was down-regulated in some cell lines, and was a statistically significant prognostic factor for poor survival of glioma patients <sup>[4]</sup>. Similar results were shown in a study of AHNAK in triple-negative breast cancer, also associating AHNAK with the AMK/MAPK signaling pathway and the Wnt/β-catenin pathway <sup>[3]</sup>. These differing effects of AHNAK in cancer may involve its regulation via TGFβ, which has both tumor suppressor and tumor promotor roles <ref name="a1" /><sup>[42]</sup>.
+
AHNAK can also act as a tumor suppressor because of its role in the TFGβ/Smad pathway <ref name="a21" />. Overexpression of AHNAK in mouse fibroblast cell resulted in increased cell-cycle arrest. Analysis of AHNAK mRNA levels in glioma demonstrated that AHNAK was down-regulated in some cell lines, and was a statistically significant prognostic factor for poor survival of glioma patients <ref name="a4" />. Similar results were shown in a study of AHNAK in triple-negative breast cancer, also associating AHNAK with the AMK/MAPK signaling pathway and the Wnt/β-catenin pathway <ref name="a3" />. These differing effects of AHNAK in cancer may involve its regulation via TGFβ, which has both tumor suppressor and tumor promotor roles <ref name="a1" /><ref name="a42">DOI:10.1016/j.ceb.2009.01.021</ref>.
=== Obesity ===
=== Obesity ===
-
In a 2010 study, AHNAK knock out mice were found to have a resistance to high-fat diet-induced obesity <sup>[43]</sup>. The authors indicated that the mechanism of resistance likely was related to changes in amino acid levels related to fat metabolism, but did not elucidate a direct mechanism for the effect that they saw. Similarly, impaired adipogenesis has been observed in AHNAK null mice <sup>[44]</sup>. Adipocyte differentiation and adipogenesis relies on the expression of Pparγ2, which in turn relies on Smad signaling. By potentiating Pparγ2 signaling, AHNAK serves as a regulator of metabolic homeostasis and might be useful in future metabolic disorder studies related to obesity <sup>[44]</sup>.
+
In a 2010 study, AHNAK knock out mice were found to have a resistance to high-fat diet-induced obesity <ref name="a43">DOI:10.1016/j.bbrc.2010.11.048</ref>. The authors indicated that the mechanism of resistance likely was related to changes in amino acid levels related to fat metabolism, but did not elucidate a direct mechanism for the effect that they saw. Similarly, impaired adipogenesis has been observed in AHNAK null mice <ref name="a44">PMID:26466345</ref>. Adipocyte differentiation and adipogenesis relies on the expression of Pparγ2, which in turn relies on Smad signaling. By potentiating Pparγ2 signaling, AHNAK serves as a regulator of metabolic homeostasis and might be useful in future metabolic disorder studies related to obesity <ref name="a44" />.
=== Aging ===
=== Aging ===
-
AHNAK has also been implicated in the aging process. In an analysis of gene expression analysis of human skeletal muscle biopsies, AHNAK displayed increased expression with increased age <sup>[38,39]</sup>. Similarly, in an analysis of gene expression profiles of multiple male age groups, high AHNAK expression levels were correlated with low maximal oxygen uptake and poor muscle fitness <sup>[40]</sup>.
+
AHNAK has also been implicated in the aging process. In an analysis of gene expression analysis of human skeletal muscle biopsies, AHNAK displayed increased expression with increased age <ref name="a37" /><ref name="a38" />. Similarly, in an analysis of gene expression profiles of multiple male age groups, high AHNAK expression levels were correlated with low maximal oxygen uptake and poor muscle fitness <ref name="a39" />.
== '''Evolutionarily Related Proteins''' ==
== '''Evolutionarily Related Proteins''' ==
-
AHNAK is ubiquitously expressed in most tissues throughout the body, and the AHNAK family of proteins is specific to vertebrates <sup>[9,12,45]</sup>. There are 3 AHNAK-like genes, AHNAK1, AHNAK2, and Periaxin. AHNAK2 is a 600-kDa protein that is hypothesized to have a similar localization and function to AHNAK1 <sup>[10]</sup>. Periaxin is a 155-kDa protein that is important in the myelination of the peripheral nervous system <sup>[46]</sup>.
+
AHNAK is ubiquitously expressed in most tissues throughout the body, and the AHNAK family of proteins is specific to vertebrates <ref name="a9" /><ref name="a12" /><ref name="a45">AceView: Gene:AHNAK, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView. Available at: https://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?db=human&c=Gene&l=AHNAK. (Accessed: 30th April 2018)</ref>. There are 3 AHNAK-like genes, AHNAK1, AHNAK2, and Periaxin. AHNAK2 is a 600-kDa protein that is hypothesized to have a similar localization and function to AHNAK1 <ref name="a10" />. Periaxin is a 155-kDa protein that is important in the myelination of the peripheral nervous system <ref name="a46">PMID:8155317</ref>.
-
All 3 of these proteins have similar genetic structure (several small exons that are upstream of a single large exon), tripartite repeat protein structure, and conserved N-terminal <scene name='78/786654/A_pdz_domain_of_ahnak2/1'>PDZ domain</scene> <sup>[12]</sup>. Both AHNAK and Periaxin have large and small isoforms <sup>[47]</sup>. Phylogenetic analysis of the 3 AHNAK family members and their isoforms indicates that the AHNAK protein family is derived from a common ancestor and that <scene name='78/786654/4cmznormal/1'>Periaxin</scene> and <scene name='78/786654/4cn0_the_pdz_domain_of_ahnak2/1'>AHNAK2</scene> are more similar than AHNAK <sup>[12]</sup>.
+
All 3 of these proteins have similar genetic structure (several small exons that are upstream of a single large exon), tripartite repeat protein structure, and conserved N-terminal <scene name='78/786654/A_pdz_domain_of_ahnak2/1'>PDZ domain</scene> <ref name="a12" />. Both AHNAK and Periaxin have large and small isoforms <ref name="a47">PMID:9488714</ref>. Phylogenetic analysis of the 3 AHNAK family members and their isoforms indicates that the AHNAK protein family is derived from a common ancestor and that <scene name='78/786654/4cmznormal/1'>Periaxin</scene> and <scene name='78/786654/4cn0_the_pdz_domain_of_ahnak2/1'>AHNAK2</scene> are more similar than AHNAK <ref name="a12" />.
-
AHNAK has previously been reported dimerizing, and the PDZ domains of AHNAK2 and Periaxin have been crystallized as homodimers (sources of AHNAK dimer and PDZ dimerization). This dimerization may be an important piece of the scaffolding functions of the proteins in the AHNAK family <sup>[48]</sup>.
+
AHNAK has previously been reported dimerizing, and the PDZ domains of AHNAK2 and Periaxin have been crystallized as homodimers (sources of AHNAK dimer and PDZ dimerization). This dimerization may be an important piece of the scaffolding functions of the proteins in the AHNAK family <ref name="a48">PMID:24675079</ref>.
== '''Links to Available AHNAK Structures''' ==
== '''Links to Available AHNAK Structures''' ==
'''AHNAK Structures'''
'''AHNAK Structures'''
-
*[[4ftg]] - An <scene name='78/786654/4ftgjustahnak/2'>AHNAK peptide</scene> in complex with the <scene name='78/786654/4ftgjusts100a10/3'>S100A10</scene>/<scene name='78/786654/4ftgjustannexin2/1'>AnxA2</scene> heterotetramer <sup>[49]</sup>.
+
*[[4ftg]] - An <scene name='78/786654/4ftgjustahnak/2'>AHNAK peptide</scene> in complex with the <scene name='78/786654/4ftgjusts100a10/3'>S100A10</scene>/<scene name='78/786654/4ftgjustannexin2/1'>AnxA2</scene> heterotetramer <ref name="a49">PMID:23275167</ref>.
-
*[[4drw]] - The ternary complex between S100A10, an Annexin A2 N-terminal peptide and an <scene name='78/786654/4drw_ahnak/1'>AHNAK peptide</scene> <sup>[29]</sup>.
+
*[[4drw]] - The ternary complex between S100A10, an Annexin A2 N-terminal peptide and an <scene name='78/786654/4drw_ahnak/1'>AHNAK peptide</scene> <ref name="a29" />.
-
*[[4hrg]] - p11-Annexin A2(N-terminal) Fusion protein complexed with <scene name='78/786654/4hrg_ahnak/1'>AHNAK1 peptide</scene> <sup>[50]</sup>.
+
*[[4hrg]] - p11-Annexin A2(N-terminal) Fusion protein complexed with <scene name='78/786654/4hrg_ahnak/1'>AHNAK1 peptide</scene> <ref name="a50">PMID:23415230</ref>.
'''AHNAK Homolog Structures'''
'''AHNAK Homolog Structures'''
-
*[[4cn0]] - An intertwined homodimer of the <scene name='78/786654/4cn0_the_pdz_domain_of_ahnak2/1'>PDZ homology domain of AHNAK2</scene> <sup>[48]</sup>.
+
*[[4cn0]] - An intertwined homodimer of the <scene name='78/786654/4cn0_the_pdz_domain_of_ahnak2/1'>PDZ homology domain of AHNAK2</scene> <ref name="a48" />.
-
*[[4cmz]] - An intertwined homodimer of the <scene name='78/786654/4cmznormal/1'>PDZ homology domain of Periaxin</scene> <sup>[48]</sup>.
+
*[[4cmz]] - An intertwined homodimer of the <scene name='78/786654/4cmznormal/1'>PDZ homology domain of Periaxin</scene> <ref name="a48" />.
</StructureSection>
</StructureSection>

Current revision

AHNAK

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 Davis TA, Loos B, Engelbrecht AM. AHNAK: the giant jack of all trades. Cell Signal. 2014 Dec;26(12):2683-93. doi: 10.1016/j.cellsig.2014.08.017. Epub, 2014 Aug 27. PMID:25172424 doi:http://dx.doi.org/10.1016/j.cellsig.2014.08.017
  2. 2.0 2.1 2.2 Hashimoto T, Amagai M, Parry DA, Dixon TW, Tsukita S, Tsukita S, Miki K, Sakai K, Inokuchi Y, Kudoh J, et al.. Desmoyokin, a 680 kDa keratinocyte plasma membrane-associated protein, is homologous to the protein encoded by human gene AHNAK. J Cell Sci. 1993 Jun;105 ( Pt 2):275-86. PMID:8408266
  3. 3.0 3.1 3.2 Chen B, Wang J, Dai D, Zhou Q, Guo X, Tian Z, Huang X, Yang L, Tang H, Xie X. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer. J Exp Clin Cancer Res. 2017 May 12;36(1):65. doi: 10.1186/s13046-017-0522-4. PMID:28494797 doi:http://dx.doi.org/10.1186/s13046-017-0522-4
  4. 4.0 4.1 4.2 Zhao Z, Xiao S, Yuan X, Yuan J, Zhang C, Li H, Su J, Wang X, Liu Q. AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma. J Cancer. 2017 Aug 25;8(15):2924-2932. doi: 10.7150/jca.20277. eCollection 2017. PMID:28928883 doi:http://dx.doi.org/10.7150/jca.20277
  5. Davis T, van Niekerk G, Peres J, Prince S, Loos B, Engelbrecht AM. Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK. Biochem Pharmacol. 2018 Feb;148:174-183. doi: 10.1016/j.bcp.2018.01.012. Epub, 2018 Jan 5. PMID:29309757 doi:http://dx.doi.org/10.1016/j.bcp.2018.01.012
  6. 6.0 6.1 6.2 6.3 Sussman J, Stokoe D, Ossina N, Shtivelman E. Protein kinase B phosphorylates AHNAK and regulates its subcellular localization. J Cell Biol. 2001 Sep 3;154(5):1019-30. doi: 10.1083/jcb.200105121. PMID:11535620 doi:http://dx.doi.org/10.1083/jcb.200105121
  7. 7.0 7.1 7.2 7.3 Benaud C, Gentil BJ, Assard N, Court M, Garin J, Delphin C, Baudier J. AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J Cell Biol. 2004 Jan 5;164(1):133-44. doi: 10.1083/jcb.200307098. Epub 2003 Dec , 29. PMID:14699089 doi:http://dx.doi.org/10.1083/jcb.200307098
  8. 8.0 8.1 8.2 Shtivelman E, Cohen FE, Bishop JM. A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5472-6. PMID:1608957
  9. 9.0 9.1 9.2 Cell atlas - AHNAK - The Human Protein Atlas. Available at: http://www.proteinatlas.org/ENSG00000124942-AHNAK/cell. (Accessed: 30th April 2018)
  10. 10.0 10.1 10.2 Komuro A, Masuda Y, Kobayashi K, Babbitt R, Gunel M, Flavell RA, Marchesi VT. The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4053-8. doi:, 10.1073/pnas.0308619101. Epub 2004 Mar 8. PMID:15007166 doi:http://dx.doi.org/10.1073/pnas.0308619101
  11. Lee HJ, Zheng JJ. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Signal. 2010 May 28;8:8. doi: 10.1186/1478-811X-8-8. PMID:20509869 doi:http://dx.doi.org/10.1186/1478-811X-8-8
  12. 12.0 12.1 12.2 12.3 12.4 de Morree A, Droog M, Grand Moursel L, Bisschop IJ, Impagliazzo A, Frants RR, Klooster R, van der Maarel SM. Self-regulated alternative splicing at the AHNAK locus. FASEB J. 2012 Jan;26(1):93-103. doi: 10.1096/fj.11-187971. Epub 2011 Sep 22. PMID:21940993 doi:http://dx.doi.org/10.1096/fj.11-187971
  13. 13.0 13.1 Hohaus A, Person V, Behlke J, Schaper J, Morano I, Haase H. The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J. 2002 Aug;16(10):1205-16. doi: 10.1096/fj.01-0855com. PMID:12153988 doi:http://dx.doi.org/10.1096/fj.01-0855com
  14. 14.0 14.1 Huang, Y. et al. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum. Mol. Genet. 17, 1855–1866 (2008).
  15. 15.0 15.1 Huang, Y. et al. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J. 21, 732–742 (2006).
  16. 16.0 16.1 Stiff T, Shtivelman E, Jeggo P, Kysela B. AHNAK interacts with the DNA ligase IV-XRCC4 complex and stimulates DNA ligase IV-mediated double-stranded ligation. DNA Repair (Amst). 2004 Mar 4;3(3):245-56. doi: 10.1016/j.dnarep.2003.11.001. PMID:15177040 doi:http://dx.doi.org/10.1016/j.dnarep.2003.11.001
  17. EMBOSS Needle < Pairwise Sequence Alignment < EMBL-EBI. Available at: https://www.ebi.ac.uk/Tools/psa/emboss_needle/. (Accessed: 2nd May 2018)
  18. AHNAK - Neuroblast differentiation-associated protein AHNAK - Homo sapiens (Human) - AHNAK gene & protein. Available at: https://www.uniprot.org/uniprot/Q09666#ptm_processing. (Accessed: 1st May 2018)
  19. 19.0 19.1 19.2 Lee IH, Lim HJ, Yoon S, Seong JK, Bae DS, Rhee SG, Bae YS. Ahnak protein activates protein kinase C (PKC) through dissociation of the PKC-protein phosphatase 2A complex. J Biol Chem. 2008 Mar 7;283(10):6312-20. doi: 10.1074/jbc.M706878200. Epub 2008, Jan 3. PMID:18174170 doi:http://dx.doi.org/10.1074/jbc.M706878200
  20. 20.0 20.1 20.2 Sekiya F, Bae YS, Jhon DY, Hwang SC, Rhee SG. AHNAK, a protein that binds and activates phospholipase C-gamma1 in the presence of arachidonic acid. J Biol Chem. 1999 May 14;274(20):13900-7. PMID:10318799
  21. 21.0 21.1 21.2 21.3 21.4 Lee IH, Sohn M, Lim HJ, Yoon S, Oh H, Shin S, Shin JH, Oh SH, Kim J, Lee DK, Noh DY, Bae DS, Seong JK, Bae YS. Ahnak functions as a tumor suppressor via modulation of TGFbeta/Smad signaling pathway. Oncogene. 2014 Sep 18;33(38):4675-84. doi: 10.1038/onc.2014.69. Epub 2014 Mar 24. PMID:24662814 doi:http://dx.doi.org/10.1038/onc.2014.69
  22. Grieve AG, Moss SE, Hayes MJ. Annexin A2 at the interface of actin and membrane dynamics: a focus on its roles in endocytosis and cell polarization. Int J Cell Biol. 2012;2012:852430. doi: 10.1155/2012/852430. Epub 2012 Feb 22. PMID:22505935 doi:http://dx.doi.org/10.1155/2012/852430
  23. 23.0 23.1 Rezvanpour A, Santamaria-Kisiel L, Shaw GS. The S100A10-annexin A2 complex provides a novel asymmetric platform for membrane repair. J Biol Chem. 2011 Nov 18;286(46):40174-83. doi: 10.1074/jbc.M111.244038. Epub, 2011 Sep 26. PMID:21949189 doi:http://dx.doi.org/10.1074/jbc.M111.244038
  24. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia. 2003 Jul;17(7):1263-93. doi: 10.1038/sj.leu.2402945. PMID:12835716 doi:http://dx.doi.org/10.1038/sj.leu.2402945
  25. Boxberg, Y. V. et al. Spinal cord injury-induced up-regulation of AHNAK, expressed in cells delineating cystic cavities, and associated with neoangiogenesis. Eur. J. Neurosci. 24, 1031–1041 (2006).
  26. Salim C, Boxberg YV, Alterio J, Fereol S, Nothias F. The giant protein AHNAK involved in morphogenesis and laminin substrate adhesion of myelinating Schwann cells. Glia. 2009 Apr 1;57(5):535-49. doi: 10.1002/glia.20782. PMID:18837049 doi:http://dx.doi.org/10.1002/glia.20782
  27. Gentil BJ, Benaud C, Delphin C, Remy C, Berezowski V, Cecchelli R, Feraud O, Vittet D, Baudier J. Specific AHNAK expression in brain endothelial cells with barrier properties. J Cell Physiol. 2005 May;203(2):362-71. doi: 10.1002/jcp.20232. PMID:15493012 doi:http://dx.doi.org/10.1002/jcp.20232
  28. Shin JH, Kim YN, Kim IY, Choi DH, Yi SS, Seong JK. Increased Cell Proliferations and Neurogenesis in the Hippocampal Dentate Gyrus of Ahnak Deficient Mice. Neurochem Res. 2015 Jul;40(7):1457-62. doi: 10.1007/s11064-015-1615-0. Epub 2015 , May 26. PMID:26007245 doi:http://dx.doi.org/10.1007/s11064-015-1615-0
  29. 29.0 29.1 29.2 Dempsey BR, Rezvanpour A, Lee TW, Barber KR, Junop MS, Shaw GS. Structure of an asymmetric ternary protein complex provides insight for membrane interaction. Structure. 2012 Oct 10;20(10):1737-45. doi: 10.1016/j.str.2012.08.004. Epub 2012 , Aug 30. PMID:22940583 doi:http://dx.doi.org/10.1016/j.str.2012.08.004
  30. Alvarez J, Hamplova J, Hohaus A, Morano I, Haase H, Vassort G. Calcium current in rat cardiomyocytes is modulated by the carboxyl-terminal ahnak domain. J Biol Chem. 2004 Mar 26;279(13):12456-61. doi: 10.1074/jbc.M312177200. Epub 2004, Jan 12. PMID:14722071 doi:http://dx.doi.org/10.1074/jbc.M312177200
  31. Matza D, Badou A, Kobayashi KS, Goldsmith-Pestana K, Masuda Y, Komuro A, McMahon-Pratt D, Marchesi VT, Flavell RA. A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation. Immunity. 2008 Jan;28(1):64-74. doi: 10.1016/j.immuni.2007.11.020. PMID:18191595 doi:http://dx.doi.org/10.1016/j.immuni.2007.11.020
  32. Matza D, Badou A, Jha MK, Willinger T, Antov A, Sanjabi S, Kobayashi KS, Marchesi VT, Flavell RA. Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis. Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9785-90. doi:, 10.1073/pnas.0902844106. Epub 2009 Jun 2. PMID:19497879 doi:http://dx.doi.org/10.1073/pnas.0902844106
  33. Chien AJ, Zhao X, Shirokov RE, Puri TS, Chang CF, Sun D, Rios E, Hosey MM. Roles of a membrane-localized beta subunit in the formation and targeting of functional L-type Ca2+ channels. J Biol Chem. 1995 Dec 15;270(50):30036-44. doi: 10.1074/jbc.270.50.30036. PMID:8530407 doi:http://dx.doi.org/10.1074/jbc.270.50.30036
  34. 34.0 34.1 Borgonovo B, Cocucci E, Racchetti G, Podini P, Bachi A, Meldolesi J. Regulated exocytosis: a novel, widely expressed system. Nat Cell Biol. 2002 Dec;4(12):955-62. doi: 10.1038/ncb888. PMID:12447386 doi:http://dx.doi.org/10.1038/ncb888
  35. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH Jr. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem. 2003 Dec 12;278(50):50466-73. Epub 2003 Sep 23. PMID:14506282 doi:http://dx.doi.org/10.1074/jbc.M307247200
  36. Kouno M, Kondoh G, Horie K, Komazawa N, Ishii N, Takahashi Y, Takeda J, Hashimoto T. Ahnak/Desmoyokin is dispensable for proliferation, differentiation, and maintenance of integrity in mouse epidermis. J Invest Dermatol. 2004 Oct;123(4):700-7. doi: 10.1111/j.0022-202X.2004.23412.x. PMID:15373775 doi:http://dx.doi.org/10.1111/j.0022-202X.2004.23412.x
  37. 37.0 37.1 Su J, Ekman C, Oskolkov N, Lahti L, Strom K, Brazma A, Groop L, Rung J, Hansson O. A novel atlas of gene expression in human skeletal muscle reveals molecular changes associated with aging. Skelet Muscle. 2015 Oct 9;5:35. doi: 10.1186/s13395-015-0059-1. eCollection 2015. PMID:26457177 doi:http://dx.doi.org/10.1186/s13395-015-0059-1
  38. 38.0 38.1 de Magalhaes JP, Curado J, Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009 Apr 1;25(7):875-81. doi: 10.1093/bioinformatics/btp073. Epub, 2009 Feb 2. PMID:19189975 doi:http://dx.doi.org/10.1093/bioinformatics/btp073
  39. 39.0 39.1 Parikh H, Nilsson E, Ling C, Poulsen P, Almgren P, Nittby H, Eriksson KF, Vaag A, Groop LC. Molecular correlates for maximal oxygen uptake and type 1 fibers. Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E1152-9. doi:, 10.1152/ajpendo.90255.2008. Epub 2008 Apr 29. PMID:18445752 doi:http://dx.doi.org/10.1152/ajpendo.90255.2008
  40. 40.0 40.1 40.2 Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res. 2010 May 1;70(9):3780-90. doi: 10.1158/0008-5472.CAN-09-4439. Epub, 2010 Apr 13. PMID:20388789 doi:http://dx.doi.org/10.1158/0008-5472.CAN-09-4439
  41. 41.0 41.1 Sudo, H. et al. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma. Int. J. Oncol. 44, 530–538 (2014).
  42. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol. 2009 Apr;21(2):166-76. doi: 10.1016/j.ceb.2009.01.021. Epub , 2009 Feb 23. PMID:19237272 doi:http://dx.doi.org/10.1016/j.ceb.2009.01.021
  43. Kim IY, Jung J, Jang M, Ahn YG, Shin JH, Choi JW, Sohn MR, Shin SM, Kang DG, Lee HS, Bae YS, Ryu DH, Seong JK, Hwang GS. 1H NMR-based metabolomic study on resistance to diet-induced obesity in AHNAK knock-out mice. Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):428-34. doi:, 10.1016/j.bbrc.2010.11.048. Epub 2010 Nov 19. PMID:21094140 doi:http://dx.doi.org/10.1016/j.bbrc.2010.11.048
  44. 44.0 44.1 Shin JH, Kim IY, Kim YN, Shin SM, Roh KJ, Lee SH, Sohn M, Cho SY, Lee SH, Ko CY, Kim HS, Choi CS, Bae YS, Seong JK. Obesity Resistance and Enhanced Insulin Sensitivity in Ahnak-/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy Expenditure. PLoS One. 2015 Oct 14;10(10):e0139720. doi: 10.1371/journal.pone.0139720., eCollection 2015. PMID:26466345 doi:http://dx.doi.org/10.1371/journal.pone.0139720
  45. AceView: Gene:AHNAK, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView. Available at: https://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?db=human&c=Gene&l=AHNAK. (Accessed: 30th April 2018)
  46. Gillespie CS, Sherman DL, Blair GE, Brophy PJ. Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron. 1994 Mar;12(3):497-508. PMID:8155317
  47. Dytrych L, Sherman DL, Gillespie CS, Brophy PJ. Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J Biol Chem. 1998 Mar 6;273(10):5794-800. PMID:9488714
  48. 48.0 48.1 48.2 Han H, Kursula P. Periaxin and AHNAK nucleoprotein 2 form intertwined homodimers through domain swapping. J Biol Chem. 2014 Mar 27. PMID:24675079 doi:http://dx.doi.org/10.1074/jbc.M114.554816
  49. Ozorowski G, Milton S, Luecke H. Structure of a C-terminal AHNAK peptide in a 1:2:2 complex with S100A10 and an acetylated N-terminal peptide of annexin A2. Acta Crystallogr D Biol Crystallogr. 2013 Jan;69(Pt 1):92-104. doi:, 10.1107/S0907444912043429. Epub 2012 Dec 20. PMID:23275167 doi:http://dx.doi.org/10.1107/S0907444912043429
  50. Oh YS, Gao P, Lee KW, Ceglia I, Seo JS, Zhang X, Ahn JH, Chait BT, Patel DJ, Kim Y, Greengard P. SMARCA3, a Chromatin-Remodeling Factor, Is Required for p11-Dependent Antidepressant Action. Cell. 2013 Feb 14;152(4):831-43. doi: 10.1016/j.cell.2013.01.014. PMID:23415230 doi:http://dx.doi.org/10.1016/j.cell.2013.01.014

Proteopedia Page Contributors and Editors (what is this?)

Patrick Wiencek

Personal tools